Stereotactic radiosurgery for trigeminal neuralgia: Current therapeutic applications, comparative efficacy, and future directions

Trigeminal neuralgia (TN) significantly impairs quality of life. While first-line medications (e.g., carbamazepine) and surgical interventions like microvascular decompression (MVD) are standard, their limitations—namely side effects, invasiveness, and recurrence—drive demand for alternatives. Stereotactic radiosurgery (SRS) has emerged as a non-invasive option, yet its comprehensive evaluation remains critical. This review examines the efficacy, safety, mechanisms, and evolving role of SRS in TN management, particularly for medication-refractory or surgically high-risk patients. The aim of this review is to critically examine the fundamentals of SRS, establish its trajectory in neurology, and identify challenges while proposing practical and workable solutions for clinical practice. We also attempt to summarize outcome determinants and provide guidance on selecting single vs. multi-fraction strategies. We analyzed original studies, meta-analyses, systematic reviews, and retrospective cohorts evaluating SRS outcomes, complications, and comparative effectiveness against pharmacotherapy, MVD, and percutaneous procedures. SRS delivers targeted radiation (70–90 Gy) to the trigeminal nerve root entry zone, achieving initial pain relief in 70–85% of patients, with 50–70% sustaining relief for ≥5 years. While slower-acting than MVD, SRS offers comparable long-term efficacy with fewer risks (e.g., stroke, infection). Facial numbness (10–30%) is the most common side effect; severe complications (e.g., radiation necrosis) are rare. SRS is particularly advantageous for TN secondary to multiple sclerosis or vascular compression, and for elderly/comorbid patients. Challenges include precision, recurrence and accessibility barriers. Future advancements may enhance precision and reduce sensory complications. Prioritizing cost-effectiveness studies and global access will solidify SRS’s role in multidisciplinary TN care.

Authors

Institutions

Publication Details

Journal
Global Neurological Insights
Published
2026-04-25
DOI
https://doi.org/10.1016/j.gni.2026.100006
Primary Topic
Trigeminal Neuralgia and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stereotactic radiosurgery for trigeminal neuralgia: Current therapeutic applications, comparative efficacy, and future directions

Patrick Tobechi Ashinze, Emmanuel Egbunu, Abdullaah Idris Agbabiaka, Aditya Gaur et al.
Global Neurological Insights
Trigeminal Neuralgia and Treatments
article

Stereotactic radiosurgery for trigeminal neuralgia: Current therapeutic applications, comparative efficacy, and future directions

Patrick Tobechi Ashinze, Emmanuel Egbunu, Abdullaah Idris Agbabiaka, Aditya Gaur, Jonathan Adeola, Dr Bruno Arekhandia, Boluwatife Adeyemo, Daniel Olumuyiwa Ogunruku, David Babatomiwa Balogun, Firebrand Isaac Inamu, Suvam Banerjee, Oluwadamilare Olatunbosun, Samuel Olatunji
article en

Abstract

Trigeminal neuralgia (TN) significantly impairs quality of life. While first-line medications (e.g., carbamazepine) and surgical interventions like microvascular decompression (MVD) are standard, their limitations—namely side effects, invasiveness, and recurrence—drive demand for alternatives. Stereotactic radiosurgery (SRS) has emerged as a non-invasive option, yet its comprehensive evaluation remains critical. This review examines the efficacy, safety, mechanisms, and evolving role of SRS in TN management, particularly for medication-refractory or surgically high-risk patients. The aim of this review is to critically examine the fundamentals of SRS, establish its trajectory in neurology, and identify challenges while proposing practical and workable solutions for clinical practice. We also attempt to summarize outcome determinants and provide guidance on selecting single vs. multi-fraction strategies. We analyzed original studies, meta-analyses, systematic reviews, and retrospective cohorts evaluating SRS outcomes, complications, and comparative effectiveness against pharmacotherapy, MVD, and percutaneous procedures. SRS delivers targeted radiation (70–90 Gy) to the trigeminal nerve root entry zone, achieving initial pain relief in 70–85% of patients, with 50–70% sustaining relief for ≥5 years. While slower-acting than MVD, SRS offers comparable long-term efficacy with fewer risks (e.g., stroke, infection). Facial numbness (10–30%) is the most common side effect; severe complications (e.g., radiation necrosis) are rare. SRS is particularly advantageous for TN secondary to multiple sclerosis or vascular compression, and for elderly/comorbid patients. Challenges include precision, recurrence and accessibility barriers. Future advancements may enhance precision and reduce sensory complications. Prioritizing cost-effectiveness studies and global access will solidify SRS’s role in multidisciplinary TN care.

Global Neurological InsightsVol. 1(2)
Burdwan Medical College & Hospital (IN), Bingham University (NG), Yeovil District Hospital NHS Foundation Trust (GB), Government of West Bengal (IN), Bowen University Teaching Hospital (NG), Federal Medical Centre (NG), Ladoke Akintola University of Technology Teaching Hospital (NG), Jos University Teaching Hospital (NG), University of Ilorin Teaching Hospital (NG), Irrua Specialist Teaching Hospital (NG), Obafemi Awolowo University Teaching Hospitals Complex (NG), Somerset NHS Foundation Trust, Ladoke Akintola University of Technology (NG)
Openalex Percentile: Top 9%
Trigeminal Neuralgia and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.